🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/04/2007 | 47,48 | 48,08 | 47,23 | 47,85 | +0,93% | 1,79% | 17.947.838 |
| 18/04/2007 | 47,32 | 47,67 | 46,99 | 47,41 | -0,64% | 1,43% | 13.989.857 |
| 17/04/2007 | 48,00 | 48,14 | 47,54 | 47,72 | -0,62% | 1,25% | 12.249.758 |
| 16/04/2007 | 47,72 | 48,31 | 47,71 | 48,02 | +0,22% | 1,26% | 15.047.394 |
| 13/04/2007 | 47,13 | 48,47 | 46,99 | 47,91 | +8,30% | 3,14% | 48.973.774 |
| 12/04/2007 | 43,44 | 44,37 | 43,37 | 44,24 | +1,56% | 2,31% | 12.325.842 |
| 11/04/2007 | 43,70 | 43,78 | 43,26 | 43,56 | -0,46% | 1,18% | 8.498.127 |
| 10/04/2007 | 43,61 | 43,88 | 43,44 | 43,76 | +0,46% | 1,03% | 6.899.089 |
| 09/04/2007 | 43,38 | 43,57 | 43,17 | 43,56 | +0,24% | 0,92% | 6.363.351 |
| 05/04/2007 | 43,18 | 43,74 | 43,04 | 43,45 | +0,37% | 1,61% | 5.892.694 |
| 04/04/2007 | 43,16 | 43,33 | 42,98 | 43,29 | -0,02% | 0,82% | 6.175.235 |
| 03/04/2007 | 43,22 | 43,48 | 42,97 | 43,30 | +0,82% | 1,19% | 8.245.874 |
| 02/04/2007 | 42,55 | 43,22 | 42,48 | 42,95 | +1,90% | 1,73% | 14.062.274 |
| 30/03/2007 | 42,06 | 42,18 | 41,35 | 42,15 | +0,50% | 1,97% | 8.228.267 |
| 29/03/2007 | 41,68 | 42,02 | 41,53 | 41,94 | +1,67% | 1,19% | 12.218.213 |
| 28/03/2007 | 41,42 | 41,64 | 41,24 | 41,25 | -0,96% | 0,97% | 11.105.237 |
| 27/03/2007 | 41,83 | 41,95 | 41,59 | 41,65 | -0,95% | 0,84% | 9.776.582 |
| 26/03/2007 | 42,23 | 42,42 | 41,75 | 42,05 | -0,85% | 1,60% | 10.087.105 |
| 23/03/2007 | 42,29 | 42,67 | 42,20 | 42,41 | +0,63% | 1,11% | 8.785.594 |
| 22/03/2007 | 41,79 | 42,34 | 41,76 | 42,15 | -0,18% | 1,39% | 9.352.771 |
| 21/03/2007 | 41,51 | 42,40 | 41,45 | 42,22 | +1,42% | 2,28% | 11.802.366 |
| 20/03/2007 | 41,31 | 41,79 | 41,16 | 41,63 | +0,48% | 1,52% | 6.212.439 |
| 19/03/2007 | 41,36 | 41,70 | 41,14 | 41,43 | +0,77% | 1,36% | 11.557.868 |
| 16/03/2007 | 41,31 | 41,63 | 41,01 | 41,12 | -0,23% | 1,50% | 12.068.663 |
| 15/03/2007 | 41,18 | 41,30 | 40,91 | 41,21 | -0,19% | 0,95% | 9.623.784 |
| 14/03/2007 | 41,65 | 41,65 | 40,80 | 41,29 | -0,23% | 2,04% | 12.927.290 |
| 13/03/2007 | 41,94 | 42,46 | 41,27 | 41,38 | -2,08% | 2,84% | 12.910.417 |
| 12/03/2007 | 42,40 | 42,65 | 42,09 | 42,26 | -0,72% | 1,33% | 8.647.153 |
| 09/03/2007 | 42,49 | 42,80 | 42,27 | 42,57 | +0,56% | 1,24% | 8.667.694 |
| 08/03/2007 | 41,97 | 42,36 | 41,97 | 42,33 | +1,14% | 0,93% | 8.774.380 |